The latest updates from RDNZ and the rare disorder community.
Have your say on how the system is working currently and identify the issues most critical to improving the effectiveness and equity of the system.
A Therapeutic Products Bill is being developed to replace the Medicine Act 1981 and establish a new regulatory scheme for therapeutic products.
Tracey's workshop was dedicated to addressing some of the challenges faced by those with rare disorders to help in creating a vision for navigating their own complex health journey.
There needs to be greater recognition of rare disorders by those who have the power to help, says New Zealand Organisation for Rare Disorders chief executive Dr Collette Bromhead.
The inaugural Rare Disease Day Awards have been established to honour and recognise ordinary people who have made a positive impact through patient support, advocacy, research and clinical practice.
Four-year-old Evie from Tauranga is one of the most unique children in the country – and the world.
Dr Greer is a former NZORD board member with a wealth of experience in not-for-profit organisations.
The Subcommittee met on 5 and 6 November 2018 and has recommended that four medicines be funded, and five be declined for funding.
Lisa spoke about the advocacy work RDNZ (formerly NZORD) does on behalf of all rare disease groups in New Zealand, as well as explained the services we offer to patients and health clinicians.
PHARMAC has released a report and action plan from their review of the role of the consumer voice in their work.